Skip to main content
padlock icon - secure page this page is secure

Bone marrow necrosis in a patient with acute promyelocytic leukemia during re-induction therapy with arsenic trioxide

Buy Article:

$52.00 + tax (Refund Policy)

Ishitsuka K, Shirahashi A, Iwao Y, Shishime M, Takamatsu Y, Takatsuka Y, Utsunomiya A, Suzumiya J, Hara S, Tamura K. Bone marrow necrosis in a patient with acute promyelocytic leukemia during re-induction therapy with arsenic trioxide.

Eur J Haematol 2004: 72: 280–284. © Blackwell Munksgaard 2004. Abstract:

Arsenic trioxide (As2O3) therapy at a daily dose of 0.15 mg/kg was given to a 60-yr-old Japanese male with refractory acute promyelocytic leukemia. White blood cell (WBC) of 6.6 × 103/l increased to 134 × 103/l following the administration of As2O3. Daily hydroxyurea (HU), and 6-mercaptopurine (6-MP) were added on days 7 and 19, respectively. Both HU and 6-MP were discontinued on day 28, when WBC declined to 54.0 × 103/l. He developed unexplained fever and profound cytopenia requiring multiple blood products transfusions. Bone marrow examination on day 42 revealed massive necrosis. Pharmacokinetics confirmed a mean maximum plasma arsenic concentration (Cpmax) and a half-life time (t1/2) of 6.9 mand 3.2 h, respectively, in the therapeutic range. This is the first case of bone marrow necrosis after standard-dose As2O3 therapy.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: acute promyelocytic leukemia; arsenic trioxide; bone marrow necrosis

Document Type: Research Article

Affiliations: 1: 1st Department of Internal Medicine, Fukuoka University 2: Medicinal Informatics and Research Units, Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan 3: Department of Hematology, Imamura Bun-in Hospital, Kagoshima, Japan

Publication date: April 1, 2004

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more